AstraZeneca

News

Janssen J&J Johnson and Johnson pharmaceutical companies

Janssen antibody could be lung cancer breakthrough

The FDA thinks a dual-target antibody from Janssen could set new standards in treatment for certain patients with lung cancer, whose disease has progressed after chemotherapy and are unlike

News

AbbVie/Allergan merger cleared in EU with brazikumab sell-of...

AbbVie and Allergan’s $63 billion merger has been cleared by European regulators, who have approved the sell-off of pipeline gastrointestinal autoimmune diseases drug brazikumab to AstraZen

News

AZ picks up $350m after selling hypertension drugs

AstraZeneca has picked up a $350m windfall after selling off five hypertension medicines to generics specialist Atnahs Pharma.

News

GW Pharma tops list of UK R&D spenders

Pharma is leading the way in R&D investment in the UK, with cannabis medicine specialist GW splurging almost 1,345% of its total revenue on research according to an analysis.

Views & Analysis

Customer experience in pharma: Getting the journey right

As part of a series of interviews in partnership with Indegene focusing on the customer experience in pharma, AstraZeneca’s global consumer marketing director Melissa Fellner tells Paul

News

AZ shares slide after warning over coronavirus impact

Shares in AstraZeneca were sharply down this morning after it warned that the hit from the COVID-19 coronavirus could have an impact lasting a few months.

Janssen antibody could be lung cancer breakthrough

AbbVie/Allergan merger cleared in EU with brazikumab sell-of...

AZ picks up $350m after selling hypertension drugs

GW Pharma tops list of UK R&D spenders

Customer experience in pharma: Getting the journey right

AZ shares slide after warning over coronavirus impact

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

AstraZeneca

Editor's Picks